Morning Breakouts

Latest California Healthline Stories

Three Studies Indicate Link Between COX-2 Inhibitors, Increased Risk for Cardiovascular, Other Events

COX-2 inhibitors are “at risk of being removed from the market” because of their link to increased risk for cardiovascular and other events, according to a “sweeping series of studies” on the medications released on Wednesday by the New England Journal of Medicine, Long Island Newsday reports.

HHS Announces Creation of Board To Monitor Drug Safety Information at FDA

In response to concerns that FDA has mishandled information about some drugs’ potential safety risks, HHS officials on Tuesday announced the creation of the FDA Drug Safety Oversight Board, which will be charged with monitoring and reporting information about potentially dangerous drug reactions, the Philadelphia Inquirer reports.

Group Plans Lawsuit Asking State To Stop Confiscation of Marijuana for Medical Purposes

Americans for Safe Access, a patient support group, plans to announce in Oakland on Tuesday a lawsuit against Gov. Arnold Schwarzenegger (R), Attorney General Bill Lockyer (D) and the California Highway Patrol asking that California cease confiscation of medical marijuana from patients, the Los Angeles Times reports.

Number of COX-2 Inhibitor Prescriptions Decreased by 43% in 2004, IMS Health Study Finds

The number of COX-2 inhibitor prescriptions decreased by 43% between December 2003 and December 2004, according to a study released on Monday by the pharmaceutical information and consulting company IMS Health, the AP/Seattle Post-Intelligencer reports.